LEADER 01827nam  2200553Ia 450 
001 9910778876003321
005 20230331015407.0
010   $a1-280-20360-9
010   $a9786610203604
010   $a0-309-59763-3
010   $a0-585-14901-1
035   $a(CKB)111004366660606
035   $a(OCoLC)43477116
035   $a(CaPaEBR)ebrary10056851
035   $a(SSID)ssj0000215893
035   $a(PQKBManifestationID)11216875
035   $a(PQKBTitleCode)TC0000215893
035   $a(PQKBWorkID)10194722
035   $a(PQKB)10886702
035   $a(MiAaPQ)EBC3376577
035   $a(Au-PeEL)EBL3376577
035   $a(CaPaEBR)ebr10056851
035   $a(CaONFJC)MIL20360
035   $a(OCoLC)49853767
035   $a(EXLCZ)99111004366660606
100   $a19910513d1991      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aOral contraceptives & breast cancer$b[electronic resource] /$fCommittee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention
210   $aWashington, D.C. $cNational Academy Press$d1991
215   $a1 online resource (195 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-04493-6 
320   $aIncludes bibliographical references and index.
606   $aBreast$xCancer$xEpidemiology$vCongresses
606   $aOral contraceptives$xSide effects$vCongresses
615  0$aBreast$xCancer$xEpidemiology
615  0$aOral contraceptives$xSide effects
676   $a616.99/449071
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778876003321
996   $aOral contraceptives & breast cancer$93854616
997   $aUNINA